The add-on effect of a Chinese herbal formula for patients with resistant hypertension: Study protocol for a pilot cohort study

doi:10.1016/S2095-4964(15)60162-5

Abstract

Background
Despite a recent American Heart Association (AHA) consensus statement emphasizing the importance of resistant hypertension (RH), its control is still a challenge for conventional medicine. The Chinese herbal formula, Qutan Huayu Fang, has been used effectively to assist antihypertensive agents in blood pressure control, but its effect for RH patients is still unclear. This pilot study aims to explore the effects of taking the formula in addition to antihypertensive medication in the management of RH.
Methods/design
A prospective cohort study will be conducted in two first-class hospitals of traditional Chinese medicine (TCM). Eligible RH patients will be classified as the experimental group (n = 100) and the control group (n = 100) based on the interventions they receive. Participants taking antihypertensive agents and the Chinese herbal formula will be in the experimental group and those taking antihypertensive agents alone will be in the control group. The whole study will last 24 weeks, including an 8-week observation and follow-up at 24 weeks. The primary outcomes, assessed against patient baseline conditions, will be the reduction of systolic blood pressure and diastolic blood pressure as well as changes in TCM symptoms and signs. These outcomes will be assessed at weeks 2, 4, 6, and 8. The reductions of blood pressure will also be assessed at week 24. Cardiac events and mortality rate will be secondary outcomes and will be assessed at weeks 8 and 24. Any adverse reactions will be recorded during the study. The causal inference method will be used to assess the effectiveness of the inclusion of TCM herbal medicine in the management of patients with RH.
Discussion
This study will determine whether the Chinese herbal formula is helpful for RH patients treated with antihypertensive agents and the findings will provide a basis for further confirmatory studies.
Trial registration number
ClinicalTrials.gov Identifier NCT01904695.

Key words: Resistant hypertension, Cohort study, Medicine, Chinese traditional, Complementary therapies, Study protocol

Ya Yuwen, Yu-qi Liu, Yan-ping Wang, Jin-gang Dai, Da-sheng Liu, Yue-xi Wang, Xue-jie Han. The add-on effect of a Chinese herbal formula for patients with resistant hypertension: Study protocol for a pilot cohort study. Journal of Integrative Medicine, 2015, 13(2): 122-128.

/ / Recommend

Add to citation manager EndNote| Reference Manager|ProCite|BibTeX|RefWorks

URL: http://www.jcimjournal.com/EN/10.1016/S2095-4964(15)60162-5

http://www.jcimjournal.com/EN/Y2015/V13/I2/122

[1]	Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM ; American Heart Association Professional Education Committee.Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation, 2008,117(25):e510-e526 doi: 10.1161/CIRCULATIONAHA.108.189141
[2]	Daugherty SL, Powers JD, Magid DJ, Tavel HM, Masoudi FA, Margolis KL, O’Connor PJ, Selby JV, Ho PM . Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation, 2012,125(13):1635-1642 doi: 10.1161/CIRCULATIONAHA.111.068064 pmid: 22379110
[3]	Sang X, Jiang Y, Wang W, Yan L, Zhao J, Peng Y, Gu W, Chen G, Liu W, Ning G . Prevalence of and risk factors for primary aldosteronism among patients with resistant hypertension in China. J Hypertens, 2013,31(7):1465-1471 doi: 10.1097/HJH.0b013e328360ddf6
[4]	Garg JP, Elliott WJ, Folker A, Izhar M, Black HR ; RUSH University Hypertension Service.Resistant hypertension revisited: a comparison of two university-based cohorts. Am J Hypertens, 2005,18(5 Pt 1):619-626 doi: 10.1016/j.amjhyper.2004.11.021 pmid: 15882544
[5]	Assadi F . Strategies to reduce the incidence of chronic kidney disease in children: time for action. J Nephrol, 2013,26(1):41-47 doi: 10.5301/jn.5000157 pmid: 22573528
[6]	Treating essential hypertension. The first choice is usually a thiazide diuretic. Prescrire Int, 2014,23(152):215-220
[7]	Ko DT, Hebert PR, Coffey CS, Sedrakyan A, Curtis JP, Krumholz HM . Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA, 2002,288(3):351-357 doi: 10.1001/jama.288.3.351
[8]	Vaur L, Genès N, Chambrelan F, Dutrey-Dupagne C, Pochoy A, Elkik F, Rauss A . Risk factors of adverse effects of angiotensin-converting enzyme inhibitors. Apropos of 30,072 patients treated by trandolapril. Therapie, 1997,52(6):599-605
[9]	Gulati V, White WB . Review of the state of renal nerve ablation for patients with severe and resistant hypertension. J Am Soc Hypertens, 2013,7(6):484-493 doi: 10.1016/j.jash.2013.07.003 pmid: 3855181
[10]	Wang SF, Shen JL, Xu Y, Li QF . Clinical effects of traditional Chinese medicine and Western medicine in treating resistant hypertension: a report of 40 cases. Sichuan Zhong Yi, 2005,23(8):47-48
[11]	Cheng GS . Effects of Jiangya Baolan Tablet combined with Western medicine in treating 60 patients with resistant hypertension due to liver-fire hyperactivity. Zhongguo Zhong Yi Yao Xian Dai Yuan Cheng Jiao Yu, 2012,10(12):21-22
[12]	Cheng ST, Wei YB, Wang JF . Clinical observation on the effects of Jiangya Xiaoling Decoction on resistant hypertension. Jilin Zhong Yi Yao, 2012,32(12):1235-1236
[13]	Song Z . Clinical effect of integration of traditional Chinese medicine and Western medicine in the treatment of 120 refractory hypertension patients. Yunnan Zhong Yi Zhong Yao Za Zhi, 2011,32(8):25-26
[14]	Wang SK . Resistant hypertension treatment with Shexiang Baoxin Pills in 40 cases. Zhongguo Zhong Yi Yao Xian Dai Yuan Cheng Jiao Yu, 2014,12(6):29-31
[15]	Hu XW . Clinical effects of traditional Chinese medicine in treating resistant hypertension. Zhongguo Yi Yao Zhi Nan, 2014,12(8):179-180
[16]	Han XJ, Liu Y, Wang LY, Jia HY, Lian ZH, Ding Y . Theoretical study on the relationship between hypertension and combined phlegm and blood stasis and five zang viscera. Zhonghua Zhong Yi Yao Za Zhi, 2009,24(3):290-293
[17]	Yuwen Y, Han XJ, Xie YM, Liu YQ, Shen SG, Lü AP . Thinking on the effectiveness assessment methods for resistant hypertension treatment with removing both phlegm and blood stasis in real-world. Zhong Yi Za Zhi, 2013,54(24):2095-2097
[18]	Han XJ, Wang LY, Li N, Liu Y, Ding Y . Dynamic clinical study on hypertension treated by synchronic removing phlegm and blood stasis, and detoxification and dredging collaterals. Zhongguo Zhong Yi Ji Zheng, 2011,20(3):377-379
[19]	Han XJ . Chinese medical diagnosis and treatment project of hypertension(First Draft). Zhonghua Zhong Yi Yao Za Zhi, 2008,23(7):611-613
[20]	Sekula P, Caputo A, Dunant A, Roujeau JC, Mockenhaupt M, Sidoroff A, Schumacher M . An application of propensity score methods to estimate the treatment effect of corticosteroids in patients with severe cutaneous adverse reactions. Pharmacoepidemiol Drug Saf, 2010,19(1):10-18 doi: 10.1002/pds.v19:1
[21]	Perkins SM, Tu W, Underhill MG, Zhou XH, Murray MD . The use of propensity scores in pharmacoepidemiologic research. Pharmacoepidemiol Drug Saf, 2000,9(2):93-101 doi: 10.1002/(SICI)1099-1557(200003/04)9:2<93::AID-PDS474>3.0.CO;2-I pmid: 19025807
[22]	Weil A . The state of the integrative medicine in the U.S. and Western World. Chin J Integr Med, 2011,17(1):6-10 doi: 10.1007/s11655-011-0600-y pmid: 21258890
[23]	Shi ZX . Optimal approach in treating and controlling hypertension — Train of thought about treatment of high blood pressure with integrative traditional and Western medicine. Chin J Integr Med, 2004,10(1):2-9 doi: 10.1007/BF02836549
[24]	Robinson N . Integrative medicine-traditional Chinese medicine, a model? Chin J Integr Med. 2011; 17(1):21-25. doi: 10.1007/s11655-011-0602-9 pmid: 21258892
[25]	Schumacher HR . West meets East — observation on integrative medicine in rheumatology from the USA. Chin J Integr Med, 2008,14(3):165-166 doi: 10.1007/s11655-008-0165-6
[26]	Grace S, Higgs J . Integrative medicine: enhancing quality in primary health care. J Altern Complem Med, 2010,16(9):945-950 doi: 10.1089/acm.2009.0437 pmid: 20809810
[27]	Boon HS, Kachan N .Integrative medicine: a tale of two clinics. BMC Complement Altern Med, 2008, 8: 32 doi: 10.1186/1472-6882-8-32 pmid: 2443104
[28]	Borisenko O, Beiqe J, Lovett EG, Hoppe UC, Bjessmo S . Cost-effectiveness of Barostim therapy for the treatment of resistant hypertension in European settings. J Hypertens, 2014,32(3):681-692 doi: 10.1097/HJH.0000000000000071
[29]	Fadl Elmula FE, Hoffmann P, Larstorp AC, Fossum E, Brekke M, Kjeldsen SE, Gjønnæss E, Hjørnholm U, Kjaer VN, Rostrup M, Os I, Stenehjem A, Høieggen A . Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension. Hypertension, 2014,63(5):991-999 doi: 10.1161/HYPERTENSIONAHA.114.03246
[30]	Pearl J. .Causal inference in statistics: An overview. Statist Surv, 2009, 3: 96-146 doi: 10.1214/09-SS057
[31]	The Methodology Center. Cause inference.[ 2013-09-09]. .

Related Articles 15

[1]	Tara Rajendran. Addressing the need for personalizing music therapy in integrative oncology. Journal of Integrative Medicine, 2022, 20(4): 281-283.
[2]	Wan-jun Guo, Yi Wang, Yu Deng, Lin-yan Cheng, Xin Liu, Ruo-fan Xi, Sheng-jie Zhu, Xin-yi Feng, Liang Hua, Kan Ze, Jian-yong Zhu, Dong-jie Guo, Fu-lun Li. Therapeutic effects of the extract of Sancao Formula, a Chinese herbal compound, on imiquimod-induced psoriasis via cysteine-rich protein 61. Journal of Integrative Medicine, 2022, 20(4): 376-384.
[3]	Cai-lian Fana, Wan-jun Caib, Meng-nan Ye, Miao Chen, Yi Dai. Qili Qiangxin, a compound herbal medicine formula, alleviates hypoxia-reoxygenation-induced apoptotic and autophagic cell death via suppression of ROS/AMPK/mTOR pathway in vitro. Journal of Integrative Medicine, 2022, 20(4): 365-375.
[4]	Shang-jin Song, Xuan Liu, Qing Ji, Da-zhi Sun, Li-juan Xiu, Jing-yu Xu, Xiao-qiang Yue. Ziyin Huatan Recipe, a Chinese herbal compound, inhibits migration and invasion of gastric cancer by upregulating RUNX3 expression. Journal of Integrative Medicine, 2022, 20(4): 355-364.
[5]	Vibha Malhotra, Joanna Harnett, Erica McIntyre, Amie Steel, Keith Wong, Bandana Saini. To “tell or not to tell”—Exploring disclosure about medicine use by people living with sleep disorders. Journal of Integrative Medicine, 2022, 20(4): 338-347.
[6]	Maryam Azimi, Hanieh Niayesh, Mahboobeh Raeiszadeh, Sedigheh Khodabandeh-shahraki. Efficacy of the herbal formula of Foeniculum vulgare and Rosa damascena on elderly patients with functional constipation: A double-blind randomized controlled tria. Journal of Integrative Medicine, 2022, 20(3): 230-236.
[7]	Marisa Casal. Improving the health and treatment success rates of in vitro fertilization patients with traditional chinese medicine: need for more robust evidence and innovative approaches. Journal of Integrative Medicine, 2022, 20(3): 187-192.
[8]	Ning Guo, Fei Wu, Mei Wu, Yuan Wang, Qing Lang, Xiao Lin, Yi Feng. Progress in the design and quality control of placeboes for clinical trials of traditional Chinese medicine . Journal of Integrative Medicine, 2022, 20(3): 204-212.
[9]	Tareq A. Wani, Zahoor A. Kaloo, Nisar A. Dangroo. Aconitum heterophyllum Wall. ex Royle: A critically endangered medicinal herb with rich potential for use in medicine. Journal of Integrative Medicine, 2022, 20(2): 104-113.
[10]	Mohammad Fazil, Sadia Nikhat. Why the “sugars” in traditional Unani formulations are a pivotal component: A viewpoint perspective. Journal of Integrative Medicine, 2022, 20(2): 91-95.
[11]	Yan-jun Lin, Kun-li Jiao, Bo Liu, Lu Fang, Shu Meng. Antiplatelet and myocardial protective effect of shexiang tongxin dropping pill in patients undergoing percutaneous coronary intervention: A randomized controlled trial. Journal of Integrative Medicine, 2022, 20(2): 126-134.
[12]	Deng-chao Wang, Miao Yu, Wen-xian Xie, Li-yan Huang, Jian Wei, Yue-hua Lei. Meta-analysis on the effect of combining Lianhua Qingwen with Western medicine to treat coronavirus disease 2019. Journal of Integrative Medicine, 2022, 20(1): 26-33.
[13]	Mahlagha Dehghan, Alireza Ghanbari, Fatemeh Ghaedi Heidari, Parvin Mangalian, Mohammad Ali Zakerid. Use of complementary and alternative medicine in general population during COVID-19 outbreak: A survey in Iran. Journal of Integrative Medicine, 2022, 20(1): 45-51.
[14]	Jose Antonio Castilla-Jimena, Isabel Ruiz-Pérez, Jesús Henares-Montiel. Impact of socioeconomic and health-related factors on consumption of homeopathic and natural remedies in Spain in 2006, 2011 and 2017. Journal of Integrative Medicine, 2022, 20(1): 52-56.
[15]	Ofer Baranovitch, Meirav Wolff-Bar, Meora Feinmesser, Chen Sade-Zaltz, Ilan Tsarfaty, Victoria Neiman. Searching for the emotional roots of breast cancer: A cross-disciplinary analysis integrating psychology, Chinese medicine, and oncology biomarkers. Journal of Integrative Medicine, 2022, 20(1): 57-64.

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed

Comments

Recommended 10

[1]	Wei-xiong Liang. Problems-solving strategies in clinical treatment guideline for traditional Chinese medicine and integrative medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 1-4
[2]	Zhao-guo Li. Discussion on English translation of commonly used sentences in traditional Chinese medicine: part one. Journal of Chinese Integrative Medicine, 2008, 6(1): 107-110
[3]	Jun Hu, Jian-ping Liu. Non-invasive physical treatments for chronic/recurrent headache. Journal of Chinese Integrative Medicine, 2008, 6(1): 31
[4]	Xue-mei Liu, Qi-fu Huang, Yun-ling Zhang, Jin-li Lou, Hong-sheng Liu, Hong Zheng. Effects of Tribulus terrestris L. saponion on apoptosis of cortical neurons induced by hypoxia-reoxygenation in rats. Journal of Chinese Integrative Medicine, 2008, 6(1): 45-50
[5]	. Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publication (Chinese version, part two). Journal of Chinese Integrative Medicine, 2010, 8(11): 1001-1005
[6]	Daniel Weber, Janelle M Wheat, Geoffrey M Currie. Inflammation and cancer: Tumor initiation, progression and metastasis,and Chinese botanical medicines. Journal of Chinese Integrative Medicine, 2010, 8(11): 1006-1013
[7]	Hong Liu , Guo-liang Zhang, Li Shen , Zhen Zeng, Bao-luo Zhou, Cheng-hai Liu, Guang Nie . Application and evaluation of a pseudotyped virus assay for screening herbs for anti-H5Nl avian influenza virus. Journal of Chinese Integrative Medicine, 2010, 8(11): 1036-1040
[8]	Zhao-guo Li . A discussion of English translation of 1995 and 1997 Chinese National Standards of Traditional Chinese Medical Terminologies for Clinical Diagnosis and Treatment. Journal of Chinese Integrative Medicine, 2010, 8(11): 1090-1096
[9]	Rui Jin, Bing Zhang. A complexity analysis of Chinese herbal property theory: the multiple formations of herbal property (Part 1). Journal of Chinese Integrative Medicine, 2012, 10(11): 1198-1205
[10]	Hui-min Liu, Xian-bo Wang, Yu-juan Chang, Li-li Gu. Systematic review and meta-analysis of randomized controlled trials of integrative medicine therapy for treatment of chronic severe hepatitis. Journal of Chinese Integrative Medicine, 2012, 10(11): 1211-1228